Mail

UK markets close in 4 hours 38 minutes

FTSE 100
8,235.15
-19.03(-0.23%)
FTSE 250
20,587.33
-117.94(-0.57%)
AIM
805.15
-3.21(-0.40%)
GBP/EUR
1.1751
-0.0004(-0.03%)
GBP/USD
1.2749
-0.0022(-0.17%)
Bitcoin GBP
53,219.04
-477.00(-0.89%)

Should you support your children at university or help them on to property ladder?

What parents should consider before making a financial decision

Oncolytics Biotech Inc. (ONC.TO)

Toronto - Toronto Real-time price. Currency in CAD

Add to watchlist

1.4900

-0.0400

(-2.61%)

At close: 03:59PM EDT

Currency in CAD

Valuation measures⁴

Market cap (intra-day)	112.38M
Enterprise value	83.90M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	5.02
Enterprise value/revenue	N/A
Enterprise value/EBITDA	N/A

Trading information

Stock price history

Beta (5Y monthly)	1.45
52-week change ³	-32.27%
S&P500 52-week change ³	26.94%
52-week high ³	4.4900
52-week low ³	1.2000
50-day moving average ³	1.5024
200-day moving average ³	1.9605

Share statistics

Avg vol (3-month) ³	64.25k
Avg vol (10-day) ³	37.13k
Shares outstanding ⁵	75.42M
Implied shares outstanding ⁶	75.42M
Float ⁸	72.21M
% held by insiders ¹	3.90%
% held by institutions ¹	1.92%
Shares short (15 May 2024) ⁴	304.12k
Short ratio (15 May 2024) ⁴	6.7
Short % of float (15 May 2024) ⁴	0.43%
Short % of shares outstanding (15 May 2024) ⁴	0.40%
Shares short (prior month 15 Apr 2024) ⁴	305.71k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	25 May 2018
Ex-dividend date ⁴	N/A
Last split factor ²	105:1000
Last split date ³	25 May 2018

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-63.83%
Return on equity (ttm)	-115.80%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-35.7M
Net income avi to common (ttm)	-28.21M
Diluted EPS (ttm)	-0.3900
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	29.6M
Total cash per share (mrq)	0.39
Total debt (mrq)	1.13M
Total debt/equity (mrq)	4.91%
Current ratio (mrq)	8.14
Book value per share (mrq)	0.31

Cash flow statement

Operating cash flow (ttm)	-28.09M
Levered free cash flow (ttm)	-17.2M